Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19

By Fang Liu, Lin Li, Mengda Xu, Juan Wu, Ding Luo, Yusi Zhu, Bi-xi Li, Xiao-yang Song, Xiang Zhou. Journal of Clinical Virology, 2020

1,012 citations recorded by the source corpus.

Highlights • The serum levels of IL-6 and CRP have a significant correlation with the severity of COVID-19.• The serum levels of IL-6 and CRP can be used as independent factors to predict disease risk.• The validity of PTC needs to be further investigated.

Subfields: Epidemiology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/6c6b9bc6ddaf7eccd9b07261b0bbfb45a28f2ccf

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. F. Cilia
2. C. Mastroianni
3. V. Panebianco
4. C. Andreoli
5. G. Masci
6. L. Manganaro
7. Simona Coco
8. F. Pugliese

Citations in the corpus

• Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis (2020, background): “Serum levels of CRP and D-dimer were similarly found to be commonly increased in COVID-19 patients and strongly associated with outcome, respectively as a consequence of the diffuse inflammatory activation and disseminated coagulopathy characterizing severe forms of disease [26, 27].”